Kane Biotech Inc.
KNBIF
$0.0451
$0.00821.56%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -43.75% | -56.04% | -66.41% | -14.74% | -16.58% |
| Total Receivables | 69.74% | -21.64% | -8.11% | -48.80% | -88.65% |
| Inventory | -38.87% | 37.82% | -8.77% | -18.63% | -69.61% |
| Prepaid Expenses | -- | 27.09% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -32.91% | -29.40% | 1,507.90% |
| Total Current Assets | -68.59% | -74.63% | -37.13% | -26.13% | 31.44% |
|
|
|||||
| Total Current Assets | -68.59% | -74.63% | -37.13% | -26.13% | 31.44% |
| Net Property, Plant & Equipment | -17.57% | -19.98% | -20.02% | -22.47% | -17.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -27.01% | -32.90% | -10.17% | -12.28% | -11.84% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -64.18% |
| Total Assets | -55.23% | -59.70% | -34.94% | -29.39% | 6.01% |
|
|
|||||
| Total Accounts Payable | 75.68% | 149.14% | 87.74% | -12.10% | -5.31% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -99.87% | -99.85% | 34.62% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.02% | -5.92% | -2.78% | -9.09% | -4.56% |
| Total Finance Division Other Current Liabilities | -82.50% | -79.26% | -31.63% | -8.76% | 187.82% |
| Total Other Current Liabilities | -82.50% | -79.26% | -31.63% | -8.76% | 187.82% |
| Total Current Liabilities | -82.40% | -79.70% | -71.31% | -66.67% | 62.14% |
|
|
|||||
| Total Current Liabilities | -82.40% | -79.70% | -71.31% | -66.67% | 62.14% |
| Long-Term Debt | -33.30% | -32.47% | -24.37% | -25.30% | -21.39% |
| Short-term Debt | -- | -- | -99.87% | -99.85% | 34.62% |
| Capital Leases | -19.11% | -20.57% | -12.73% | -15.12% | -11.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 21.19% |
| Total Liabilities | -76.10% | -73.14% | -64.68% | -60.77% | 40.77% |
|
|
|||||
| Common Stock & APIC | 2.62% | -4.46% | 4.48% | 0.83% | 3.57% |
| Retained Earnings | 22.88% | 25.03% | 17.69% | 19.17% | -13.56% |
| Treasury Stock & Other | -90.27% | -57.09% | -52.49% | 28.05% | -- |
| Total Common Equity | 90.89% | 85.84% | 92.50% | 91.78% | -51.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 90.89% | 85.84% | 92.50% | 91.78% | -51.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -6.20% |
| Total Equity | 88.79% | 82.22% | 90.17% | 88.82% | -75.84% |
|
|
|||||